Thrombolysis in submassive pulmonary embolism? Yes

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 6, 2003, Pages 1127-1129

  Konstantinides, S ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; BLEEDING; DRUG EFFECT; FIBRINOLYTIC THERAPY; HEMODYNAMICS; HUMAN; LUNG EMBOLISM; METHODOLOGY; MORTALITY; RISK ASSESSMENT; TREATMENT OUTCOME;

FIBRINOLYTIC AGENTS; HEMODYNAMIC PHENOMENA; HEMORRHAGE; HUMANS; PULMONARY EMBOLISM; RISK ASSESSMENT; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 2142646375     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00335.x     Document Type: Note

References (25)

1. Dalen JE, Alpert JS, Hirsch J. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Arch Intern Med 1997; 157: 2550-6.
2. Dalen JE. The uncertain role of thrombolytic therapy in the treatment of pulmonary embolism. Arch Intern Med 2002; 162: 2521-3.
3. Miller GA, Sutton GC, Kerr IH, Gibson RV, Honey M. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Heart J 1971; 33: 616.
4. Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based metaanalysis. Arch Intern Med 2002; 162: 2537-41.
5. Thabut G, Thabut D, Myers RP, Bernard-Chabert B, Marrash-Chahla R, Mal H, Fournier M. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol 2002; 40: 1660-7.
6. The urokinase pulmonary embolism trial. A national cooperative study. Circulation 1973; 47: 111-108.
7. Kasper W, Konstantinides S, Geibel A, Olschewski M,Heinrich F, Grosser KD, Rauber K, Iversen S, Redecker M, Kienast J. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30: 1165-71.
8. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, Taveira da Silva AM, Come PC, Lee RT, Parker JA. Alteplase versus heparin in acute pulmonary embolism. randomised trial assessing rightventricular functionand pulmonaryperfusion. Lancet 1993; 341: 507-11.
9. Konstantinides S, Tiede N, Geibel A, Olschewski M, Just H, KasperW. Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am J Cardiol 1998; 82: 966-70.
10. Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative study. JAMA 1974; 229: 1606-13.
11. Levine M, Hirsh J,Weitz J, Cruickshank M, Neemeh J, Turpie AG, Gent M. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 1990; 98: 1473-9.
12. Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O, Zonzin P, Zanuttini D, Barbaresi F, Agnelli G. PAIMS 2. alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 1992; 20: 520-6.
13. Meyer G, Sors H, Charbonnier B, Kasper W, Bassand JP, Kerr IH, Lesaffre E, Vanhove P, Verstraete M. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol 1992; 19: 239-45.
14. Sors H, Pacouret G, Azarian R, Meyer G, Charbonnier B, Simonneau G. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest 1994; 106: 712-7.
15. Kanter DS, Mikkola KM, Patel SR, Parker JA, Goldhaber SZ. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest 1997; 111: 1241-5.
16. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-50.
17. Hamel E, Pacouret G, Vincentelli D, Forissier JF, Peycher P, Pottier JM, Charbonnier B. Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest 2001; 120: 120-5.
18. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-9.
19. Meyer G, Gisselbrecht M, Diehl JL, Journois D, Sors H. Incidence and predictors ofmajor hemorrhagic complications fromthrombolytic therapy in patients with massive pulmonaryembolism. Am J Med 1998; 105: 472-7.
20. Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser KD, Rauber K, Iversen S, Redecker M, Kienast J, Just H, Kasper W. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 1997; 96: 882-8.
21. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism. pathophysiologic factors, detection, and therapeutic implications. Am Heart J 1995; 130: 1276-82.
22. Kasper W, Konstantinides S, Geibel A, Tiede N, Krause T, Just H. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 1997; 77: 346-9.
23. Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camaiti A, Santoro G, Conti A, Agnelli G, Berni G. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101: 2817-22.
24. Giannitsis E, Muller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, Katus HA. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211-7.
25. Konstantinides S,Geibel A,OlschewskiM,KasperW, HruskaN, Jäckle S, Binder L. Importance of cardiac troponins I and T in risk stratification of patientswithacutepulmonaryembolism. Circulation 2002; 106: 1263-8.